TSX open
Loading markets…

Advertisement

Stocks/TSX/MDNA

Medicenna Therapeutics Corp (MDNA : TSX)

Common Stock

$0.36

CAD

+0.01 (2.86%)

Last updated: 2026-07-31

Get MDNA alerts:

MDNA

Medicenna Therapeutics Corp

Source:WealthAwesomeWealthAwesome
$0.07 (-16.28%)
30 day period
$0.34$0.39$0.43Jun 19Jul 13Jul 31

Performance

1 Day

+2.86%

1 Week

+2.86%

1 Month

-8.86%

YTD

-64.00%

Key Statistics

Market Cap

$33.23M

52W High

$1.97

52W Low

$0.34

P/E Ratio

-

50 Day MA

$0.40

200 Day MA

$0.82

Beta

1.89

Dividend Yield

-

Advertisement

Technical Indicators

Price vs 50-Day SMA

Below 50 SMA

Price vs 200-Day SMA

Below 200 SMA

Recent Price History

DateOpenHighLowCloseAdj CloseVolume
7/31/2026$0.34$0.36$0.34$0.36$0.3614,480
7/30/2026$0.35$0.35$0.34$0.35$0.3579,482
7/29/2026$0.36$0.36$0.34$0.35$0.3525,054
7/28/2026$0.35$0.35$0.35$0.35$0.3534,103
7/27/2026$0.36$0.36$0.34$0.34$0.3475,808
7/24/2026$0.35$0.35$0.35$0.35$0.3513,732
7/23/2026$0.35$0.35$0.34$0.34$0.3417,082
7/22/2026$0.35$0.35$0.34$0.35$0.3530,054
7/21/2026$0.35$0.35$0.34$0.35$0.3530,502
7/20/2026$0.35$0.35$0.34$0.35$0.3549,968

Analyst Price Targets

Based on analyst covering MDNA

📈

Wall Street analysts forecast MDNA stock price to rise 788.9% over the next 12 months.

Consensus

Bullish

Based on avg. target vs last close (formal rating unavailable for Canadian listings)

Avg. Target

C$3.20

+788.9% Upside

Current Price

C$0.36

Last close

Compare analyst targets across the TSX & TSXV →

Analyst ratings and price targets are updated periodically. Not financial advice.

Wealth Awesome Price Forecast

WA Model

Statistical 90-day price range based on MDNA's historical volatility

HistoricalForecast68%95%
C$0.19C$0.29C$0.39C$0.49C$0.58C$0.68TodayMar 25May 29Jul 31Sep 12Oct 26Dec 8

30-Day Vol

34.7%

Annualized

90-Day Vol

67.9%

Annualized

Trend (90d)

-50.0%

Annualized drift

90d Mean

C$0.30

Expected price

HorizonExpected68% Range (1σ)
30 trading daysC$0.34C$0.30C$0.38
60 trading daysC$0.32C$0.27C$0.38
90 trading daysC$0.30C$0.24C$0.37

Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.

About Medicenna Therapeutics Corp

Medicenna Therapeutics Corp., a clinical-stage immunotherapy company, engages in the development and commercialization of Superkines and empowered Superkines for the treatment of cancer, inflammation, and immune-mediated diseases. It develops bizaxofusp, an interleukin- 4 (IL-4) targeted therapy for the treatment of recurrent glioblastoma. The company also develops MDNA11, an interleukin-2 (IL-2) to activate anti-cancer immune cells over immunosuppressive Tregs; and MDNA113, a tumor-targeting and activatable bifunctional anti-PD-1-IL-2 superkine for cancer. In addition, its preclinical products are MDNA209, an IL-2/IL-15 antagonist for autoimmune diseases, such as multiple sclerosis and graft versus host diseases, including transplant rejection; and MDNA413, an IL-4/IL-13 antagonist to inflammatory, asthma, and atopic dermatitis, as well as other allergic diseases. Medicenna Therapeutics Corp. is headquartered in Toronto, Canada.

Financials

Revenue (TTM)
$0
EBITDA
$-22.40M
Profit Margin
0.00%
ROE (TTM)
-170.64%
EPS (Diluted)
-0.22
Book Value
0.03

Classification

Sector
Health Care
Industry
Biotechnology
Group
Pharmaceuticals, Biotechnology & Life Sciences

7 stocks to buy and hold forever

Blue-chip dividend stocks for long-term wealth building.

Get the FREE Report

Advertisement

Common Questions About MDNA

Market movers

Recent TSX movers

Top 1-day gainers — updated from our Canadian movers feed.

All movers →
TickerNamePrice1D
TCTucows Inc.$21.73+58.85%
PPRPrairie Provident Resources Inc$0.45+30.43%
BHCBausch Health Companies Inc$9.65+14.47%
CJR-BCorus Entertainment Inc$0.04+14.29%
RTGRTG Mining Inc$0.04+14.29%
GTEGran Tierra Energy Inc$10.52+12.15%
FSYForsys Metals Corp.$0.49+11.36%
TVA-BTVA Group Inc$2.31+10.53%

MDNA.TO news timeline

15 articles covering MDNA.TO, most recent first

Latest

Why Medicenna Therapeutics Corp stock is rising today

Stocks

Advertisement